{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:53:26Z","timestamp":1792612406552,"version":"4.5.0"},"reference-count":39,"publisher":"American Society for Clinical Investigation","issue":"21","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"crossref","award":["NIAMS AR42309"],"award-info":[{"award-number":["NIAMS AR42309"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100019921","name":"National Scleroderma Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100019921","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,8]]},"abstract":"<jats:p>Activation of TLR4 by its cognate damage-associated molecular patterns (DAMPs) elicits potent profibrotic effects and myofibroblast activation in systemic sclerosis (SSc), while genetic targeting of TLR4 or its DAMPs in mice accelerates fibrosis resolution. To prevent aberrant DAMP\/TLR4 activity, a variety of negative regulators evolved to dampen the magnitude and duration of the signaling. These include radioprotective 105 kDa (RP105), a transmembrane TLR4 homolog that competitively inhibits DAMP recognition of TLR4, blocking TLR4 signaling in immune cells. The role of RP105 in TLR4-dependent fibrotic responses in SSc is unknown. Using unbiased transcriptome analysis of skin biopsies, we found that levels of both TLR4 and its adaptor protein MD2 were elevated in SSc skin and significantly correlated with each other. Expression of RP105 was negatively associated with myofibroblast differentiation in SSc. Importantly, RP105-TLR4 association was reduced, whereas TLR4-TLR4 showed strong association in fibroblasts from patients with SSc, as evidenced by PLA assays. Moreover, RP105 adaptor MD1 expression was significantly reduced in SSc skin biopsies and explanted SSc skin fibroblasts. Exogenous RP105-MD1 abrogated, while loss of RP105 exaggerated, fibrotic cellular responses. Importantly, ablation of RP105 in mice was associated with augmented TLR4 signaling and aggravated skin fibrosis in complementary disease models. Thus, we believe RP105-MD1 to be a novel cell-intrinsic negative regulator of TLR4-MD2\u2013driven sustained fibroblast activation, representing a critical regulatory network governing the fibrotic process. Impaired RP105 function in SSc might contribute to persistence of progression of the disease.<\/jats:p>","DOI":"10.1172\/jci.insight.160684","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T12:08:09Z","timestamp":1663848489000},"source":"Crossref","is-referenced-by-count":10,"title":["Deficiency of inhibitory TLR4 homolog RP105 exacerbates fibrosis"],"prefix":"10.1172","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4681-8783","authenticated-orcid":true,"given":"Wenxia","family":"Wang","sequence":"first","affiliation":[{"name":"Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, Illinois, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarna","family":"Bale","sequence":"additional","affiliation":[{"name":"Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, Illinois, USA."},{"name":"Michigan Scleroderma Program, Division of Rheumatology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharath","family":"Yalavarthi","sequence":"additional","affiliation":[{"name":"Michigan Scleroderma Program, Division of Rheumatology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Verma","sequence":"additional","affiliation":[{"name":"Michigan Scleroderma Program, Division of Rheumatology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7149-9115","authenticated-orcid":true,"given":"Pei-Suen","family":"Tsou","sequence":"additional","affiliation":[{"name":"Michigan Scleroderma Program, Division of Rheumatology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0533-2763","authenticated-orcid":true,"given":"Ken M.","family":"Calderone","sequence":"additional","affiliation":[{"name":"Derpartment of Dermatology, University of Michigan, Ann Arbor, Michigan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibyendu","family":"Bhattacharyya","sequence":"additional","affiliation":[{"name":"Michigan Scleroderma Program, Division of Rheumatology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Fisher","sequence":"additional","affiliation":[{"name":"Derpartment of Dermatology, University of Michigan, Ann Arbor, Michigan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Varga","sequence":"additional","affiliation":[{"name":"Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, Illinois, USA."},{"name":"Michigan Scleroderma Program, Division of Rheumatology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Bhattacharyya","sequence":"additional","affiliation":[{"name":"Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, Illinois, USA."},{"name":"Michigan Scleroderma Program, Division of Rheumatology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/672395","article-title":"DAMPening inflammation by modulating TLR signalling","volume":"2010","author":"Piccinini","year":"2010","journal-title":"Mediators Inflamm"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1863"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/ni986"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/science.1087262"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00421-07"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11703"},{"issue":"232","key":"B7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008264","article-title":"FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling","volume":"6","author":"Bhattacharyya","year":"2014","journal-title":"Sci Transl Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2012.09.007"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/ni1198"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2106"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3934\/Allergy.2021009"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.1.23"},{"issue":"7","key":"B13","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.4049\/jimmunol.154.7.3333","article-title":"RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family","volume":"154","author":"Miyake","year":"1995","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.149"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31139"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan5174"},{"issue":"1","key":"B17","doi-asserted-by":"crossref","DOI":"10.1111\/asj.13368","article-title":"Differentiation of skeletal muscle mesenchymal progenitor cells to myofibroblasts is reversible","volume":"91","author":"Takeuchi","year":"2020","journal-title":"Anim Sci J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98850"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2017.09.011"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.472"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/wound.2017.0732"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700331"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.2"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1042\/CS20130367"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2018.08.003"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2014.10.027"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05379-w"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12620"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2018.11.025"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14407"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.820962"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2020.11242"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108904"},{"key":"B34"},{"key":"B35"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.151037"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/art.20996"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15895"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2019"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/160684\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:27:39Z","timestamp":1779146859000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/160684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":39,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11,8]]},"published-print":{"date-parts":[[2022,11,8]]}},"alternative-id":["10.1172\/jci.insight.160684"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.160684","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"article-number":"e160684"}}